An integrated biosensing framework that treats readout reliability as an explicit engineering objective rather than a post hoc correction problem, and establishes a generalizable strategy for constructing trustworthy POCT systems in which chemical signal generation and digital interpretation are co-designed.
By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.
Ö. Altıntaş, Adil Denizli· Electronics· 0 citations
A review of recent progress in AI-assisted biosensor development highlights how AI can link molecular design, device engineering, and signal interpretation to accelerate the development of next-generation biosensors.
Yunseon Han, Haebin Jo, Minyoung Ju et al.· Biosensors· 0 citations
Functionalized design is presented as an application‐backward, cross‐scale framework that links clinical needs and biomarker–matrix constraints with recognition chemistry, biointerfaces, functional materials, transduction architectures, calibration, data interpretation, manufacturability, and validation.
Ya-Nan Li, Yang Zhou, Meng Yang et al.· Advanced Materials & Technol...· 0 citations
This review summarizes the evolution of SERS-based bacterial detection from fundamental nanomaterials to integrated clinical diagnostic platforms and reveals a research shift from maximizing electromagnetic enhancement toward overcoming matrix effects in clinical samples and ensuring robustness.
Yueqi Yang, Jing Li, Xinyi Hu et al.· Biosensors· 0 citations
A single-pot electrochemical sensing platform that enables rapid and ultrasensitive quantitative detection of AD biomarkers directly from untreated blood or plasma within 20 min of collection, without sample preparation, washing, or using additional reagents is reported.
Xue-Wei Du, Tao-Ping Zhang, Zhongzhong Wan et al.· ACS Sensors· 0 citations
This review highlights the comparison of two electrochemical platforms—antibody-based platform (immunosensor) and aptamer-based platform (aptasensor)—developed from 2021 to 2026 for four important BC biomarkers, human epidermal growth factor receptor 2 (HER2), carbohydrate antigen 15-3 (CA 15-3), carcinoembryonic antig...
Manasa T L, Rajeshkumar Upadhyaya, D. H B· International Journal For Mu...· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduOct 15, 2026
A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.
MIT News · Artificial Intelligence· news.mit.eduOct 15, 2026
AI is moving beyond impressive demos. After World Summit AI 2026 in Amsterdam, GPT-Lab's Muhammad Waseem reflects on what organizations need to make AI agents reliable, responsible and genuinely useful in everyday work. The post Building trustworthy AI: The role of AI harnesses, intent contracts and evals appeared first on GPT-Lab.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
